{"entity":{"type":"insider","cik":"0001557930","url":"/insider/0001557930","json_url":"/insider/0001557930.json","name":"Erbez Georgia","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":13,"n_filings":10,"first":"2013-09-03","last":"2026-02-09","span_basis":"filed_date"},"name_variants":[{"name":"Erbez Georgia","source":"filing","n_filings":10,"first_seen":"2013-09-03","last_seen":"2026-02-09"}],"transactions":[{"id":5995402,"accession":"0001610717-26-000046","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-26-000046","line_url":"/filing/0001610717-26-000046#line-1","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS, INC.","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer","role_mark":"O","role_mark_label":"Officer","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"See Remarks","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":3826.0,"shares_display":"3,826","price_per_share":1.3071,"price_display":"1.31","price_state":"stated","total_value":5000.9646,"total_display":"5,000.96","total_whole":"5,001","shares_owned_after":66810.0,"shares_owned_after_display":"66,810","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-02-06","filed_date":"2026-02-09","scope":"insider"},{"id":4290699,"accession":"0001610717-25-000362","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001610717-25-000362","line_url":"/filing/0001610717-25-000362#line-1","is_derivative":false,"issuer_cik":"0001200375","issuer_name":"CODEXIS, INC.","issuer_ticker":"CDXS","issuer_name_source":null,"issuer_url":"/issuer/0001200375","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":6239.0,"shares_display":"6,239","price_per_share":2.505,"price_display":"2.50","price_state":"stated","total_value":15628.695,"total_display":"15,628.70","total_whole":"15,629","shares_owned_after":70636.0,"shares_owned_after_display":"70,636","ownership_form":"D","is_10b5_1":null,"transaction_date":"2025-10-13","filed_date":"2025-10-15","scope":"insider"},{"id":4629070,"accession":"0001209191-21-057342","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-21-057342","line_url":"/filing/0001209191-21-057342#line-1","is_derivative":false,"issuer_cik":"0001557930","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001557930","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10300.0,"shares_display":"10,300","price_per_share":8.1,"price_display":"8.10","price_state":"stated","total_value":83430.0,"total_display":"83,430.00","total_whole":"83,430","shares_owned_after":19215.0,"shares_owned_after_display":"19,215","ownership_form":"I","is_10b5_1":null,"transaction_date":"2021-09-22","filed_date":"2021-09-22","scope":"insider"},{"id":2784438,"accession":"0001209191-20-047804","txn_seq":2,"anchor":"line-2","filing_url":"/filing/0001209191-20-047804","line_url":"/filing/0001209191-20-047804#line-2","is_derivative":false,"issuer_cik":"0001557930","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001557930","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":5000.0,"shares_display":"5,000","price_per_share":11.4,"price_display":"11.40","price_state":"stated","total_value":57000.0,"total_display":"57,000.00","total_whole":"57,000","shares_owned_after":8915.0,"shares_owned_after_display":"8,915","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-19","filed_date":"2020-08-20","scope":"insider"},{"id":2784434,"accession":"0001209191-20-047804","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-047804","line_url":"/filing/0001209191-20-047804#line-1","is_derivative":false,"issuer_cik":"0001557930","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001557930","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2098.0,"shares_display":"2,098","price_per_share":11.6,"price_display":"11.60","price_state":"stated","total_value":24336.8,"total_display":"24,336.80","total_whole":"24,337","shares_owned_after":3915.0,"shares_owned_after_display":"3,915","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-08-18","filed_date":"2020-08-20","scope":"insider"},{"id":3167233,"accession":"0001209191-20-044576","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-044576","line_url":"/filing/0001209191-20-044576#line-1","is_derivative":false,"issuer_cik":"0001557930","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001557930","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1817.0,"shares_display":"1,817","price_per_share":10.92,"price_display":"10.92","price_state":"stated","total_value":19841.64,"total_display":"19,841.64","total_whole":"19,842","shares_owned_after":1817.0,"shares_owned_after_display":"1,817","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-07-31","filed_date":"2020-08-04","scope":"insider"},{"id":3188017,"accession":"0001209191-20-004581","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001209191-20-004581","line_url":"/filing/0001209191-20-004581#line-1","is_derivative":false,"issuer_cik":"0001557930","issuer_name":"Harpoon Therapeutics, Inc.","issuer_ticker":"HARP","issuer_name_source":null,"issuer_url":"/issuer/0001557930","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":6700.0,"shares_display":"6,700","price_per_share":14.0922,"price_display":"14.09","price_state":"stated","total_value":94417.74,"total_display":"94,417.74","total_whole":"94,418","shares_owned_after":6700.0,"shares_owned_after_display":"6,700","ownership_form":"I","is_10b5_1":null,"transaction_date":"2020-01-21","filed_date":"2020-01-23","scope":"insider"},{"id":4979816,"accession":"0001587221-17-000018","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001587221-17-000018","line_url":"/filing/0001587221-17-000018#line-1","is_derivative":false,"issuer_cik":"0001557930","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001557930","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer (CFO and Chief Business Officer)","role_mark":"O","role_mark_label":"Officer (CFO and Chief Business Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"CFO and Chief Business Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":68000.0,"shares_display":"68,000","price_per_share":1.32,"price_display":"1.32","price_state":"stated","total_value":89760.0,"total_display":"89,760.00","total_whole":"89,760","shares_owned_after":115750.0,"shares_owned_after_display":"115,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2017-05-25","filed_date":"2017-05-25","scope":"insider"},{"id":2876559,"accession":"0001557930-16-000008","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001557930-16-000008","line_url":"/filing/0001557930-16-000008#line-1","is_derivative":false,"issuer_cik":"0001557930","issuer_name":"Zosano Pharma Corp","issuer_ticker":"ZSAN","issuer_name_source":null,"issuer_url":"/issuer/0001557930","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer (Interim CFO)","role_mark":"O","role_mark_label":"Officer (Interim CFO)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Interim CFO","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":47750.0,"shares_display":"47,750","price_per_share":1.32,"price_display":"1.32","price_state":"stated","total_value":63030.0,"total_display":"63,030.00","total_whole":"63,030","shares_owned_after":47750.0,"shares_owned_after_display":"47,750","ownership_form":"D","is_10b5_1":null,"transaction_date":"2016-08-19","filed_date":"2016-08-22","scope":"insider"},{"id":6528878,"accession":"0001140361-14-021384","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001140361-14-021384","line_url":"/filing/0001140361-14-021384#line-1","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"Raptor Pharmaceutical Corp","issuer_ticker":"RPTP","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":16100.0,"shares_display":"16,100","price_per_share":7.9,"price_display":"7.90","price_state":"stated","total_value":127190.0,"total_display":"127,190.00","total_whole":"127,190","shares_owned_after":16100.0,"shares_owned_after_display":"16,100","ownership_form":"D","is_10b5_1":null,"transaction_date":"2014-05-13","filed_date":"2014-05-15","scope":"insider"},{"id":4305706,"accession":"0001209191-13-042774","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001209191-13-042774","line_url":"/filing/0001209191-13-042774","is_derivative":false,"issuer_cik":"0001070698","issuer_name":"Raptor Pharmaceutical Corp","issuer_ticker":"RPTP","issuer_name_source":null,"issuer_url":"/issuer/0001070698","owner_cik":"0001557930","owner_name":"Erbez Georgia","owner_display_name":"Erbez Georgia","owner_url":"/insider/0001557930","role":"Officer (Chief Financial Officer)","role_mark":"O","role_mark_label":"Officer (Chief Financial Officer)","role_mark_generic":"Officer","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":"Chief Financial Officer","security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":7400.0,"shares_display":"7,400","price_per_share":13.422363513513513,"price_display":"13.42","price_state":"stated","total_value":99325.49,"total_display":"99,325.49","total_whole":"99,325","shares_owned_after":2500.0,"shares_owned_after_display":"2,500","ownership_form":"D","is_10b5_1":null,"transaction_date":"2013-08-30","filed_date":"2013-09-03","scope":"insider","n_lines":3}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":13,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":8,"open_market":true},{"code":"S","label":"Open-market sale","n":5,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":13},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001200375","name":"CODEXIS, INC.","url":"/issuer/0001200375","role":"Officer","n_filings":2,"first_seen":"2025-10-15","last_seen":"2026-02-09"},{"type":"issuer","type_label":"ISSUER","cik":"0001708493","name":"Harpoon Therapeutics, Inc.","url":"/issuer/0001708493","role":"Officer (Chief Financial Officer)","n_filings":4,"first_seen":"2020-01-23","last_seen":"2021-09-22"},{"type":"issuer","type_label":"ISSUER","cik":"0001587221","name":"Zosano Pharma Corp","url":"/issuer/0001587221","role":"Officer (CFO and Chief Business Officer)","n_filings":2,"first_seen":"2016-08-22","last_seen":"2017-05-25"},{"type":"issuer","type_label":"ISSUER","cik":"0001070698","name":"Raptor Pharmaceutical Corp","url":"/issuer/0001070698","role":"Officer (Chief Financial Officer)","n_filings":2,"first_seen":"2013-09-03","last_seen":"2014-05-15"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001557930","retrieved_at":"2026-08-23T12:28:38+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}